Christine M Swanson1, Prajakta Shanbhag2, Emma J Tussey2, Corey A Rynders2, Kenneth P Wright3,4, Wendy M Kohrt2. 1. Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, 12801 E. 17th Ave, Mail Stop 8106, Aurora, CO, 80045, USA. Christine.Swanson@CUAnschutz.edu. 2. Division of Geriatric Medicine, University of Colorado Anschutz Medical Campus, and Eastern Colorado VA Geriatric, Research, Education, and Clinical Center (GRECC), Aurora, CO, USA. 3. Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, 12801 E. 17th Ave, Mail Stop 8106, Aurora, CO, 80045, USA. 4. Sleep and Chronobiology Laboratory, Department of Integrative Physiology, University of Colorado Boulder, Boulder, CO, USA.
Abstract
PURPOSE: The goal of this study was to determine the bone turnover marker (BTM) response to insufficient and subsequent recovery sleep, independent of changes in posture, body weight, and physical activity. METHODS: Healthy men (N = 12) who habitually slept 7-9 h/night were admitted to an inpatient sleep laboratory for a baseline 8 h/night sleep opportunity followed by six nights of insufficient sleep (5 h/night). Diet, physical activity, and posture were controlled. Serum markers of bone formation (osteocalcin, PINP) and resorption (β-CTX) were obtained over 24 h at baseline and on the last night of sleep restriction, and on fasted samples obtained daily while inpatient and five times after discharge over 3 weeks. Maximum likelihood estimates in a repeated measures model were used to assess the effect of insufficient and subsequent recovery sleep on BTM levels. RESULTS: There was no statistically or clinically significant change in PINP (p = 0.53), osteocalcin (p = 0.66), or β-CTX (p = 0.10) in response to six nights of insufficient sleep. There were no significant changes in BTMs from the inpatient stay through 3 weeks of recovery sleep (all p [Formula: see text] 0.63). On average, body weight was stable during the inpatient stay (Δweight = - 0.55 ± 0.91 kg, p = 0.06). CONCLUSION: No significant changes in serum BTMs were observed after six nights of insufficient or subsequent recovery sleep in young healthy men. Changes in weight and physical activity may be required to observe significant BTM change in response to sleep and circadian disruptions. Clinical Trials Registration Registered at ClinicalTrials.gov (NCT03733483) on November 7, 2018.
PURPOSE: The goal of this study was to determine the bone turnover marker (BTM) response to insufficient and subsequent recovery sleep, independent of changes in posture, body weight, and physical activity. METHODS: Healthy men (N = 12) who habitually slept 7-9 h/night were admitted to an inpatient sleep laboratory for a baseline 8 h/night sleep opportunity followed by six nights of insufficient sleep (5 h/night). Diet, physical activity, and posture were controlled. Serum markers of bone formation (osteocalcin, PINP) and resorption (β-CTX) were obtained over 24 h at baseline and on the last night of sleep restriction, and on fasted samples obtained daily while inpatient and five times after discharge over 3 weeks. Maximum likelihood estimates in a repeated measures model were used to assess the effect of insufficient and subsequent recovery sleep on BTM levels. RESULTS: There was no statistically or clinically significant change in PINP (p = 0.53), osteocalcin (p = 0.66), or β-CTX (p = 0.10) in response to six nights of insufficient sleep. There were no significant changes in BTMs from the inpatient stay through 3 weeks of recovery sleep (all p [Formula: see text] 0.63). On average, body weight was stable during the inpatient stay (Δweight = - 0.55 ± 0.91 kg, p = 0.06). CONCLUSION: No significant changes in serum BTMs were observed after six nights of insufficient or subsequent recovery sleep in young healthy men. Changes in weight and physical activity may be required to observe significant BTM change in response to sleep and circadian disruptions. Clinical Trials Registration Registered at ClinicalTrials.gov (NCT03733483) on November 7, 2018.
Authors: Sanjay R Patel; Jia Weng; Michael Rueschman; Katherine A Dudley; Jose S Loredo; Yasmin Mossavar-Rahmani; Maricelle Ramirez; Alberto R Ramos; Kathryn Reid; Ashley N Seiger; Daniela Sotres-Alvarez; Phyllis C Zee; Rui Wang Journal: Sleep Date: 2015-09-01 Impact factor: 5.849
Authors: Christine M Swanson; Steven A Shea; Wendy M Kohrt; Kenneth P Wright; Sean W Cain; Mirjam Munch; Nina Vujović; Charles A Czeisler; Eric S Orwoll; Orfeu M Buxton Journal: J Clin Endocrinol Metab Date: 2020-07-01 Impact factor: 5.958
Authors: Christine M Swanson; Wendy M Kohrt; Orfeu M Buxton; Carol A Everson; Kenneth P Wright; Eric S Orwoll; Steven A Shea Journal: Metabolism Date: 2017-12-09 Impact factor: 8.694
Authors: Christine M Swanson; Steven A Shea; Pamela Wolfe; Sean W Cain; Mirjam Munch; Nina Vujovic; Charles A Czeisler; Orfeu M Buxton; Eric S Orwoll Journal: J Clin Endocrinol Metab Date: 2017-10-01 Impact factor: 5.958
Authors: Robert H Eckel; Christopher M Depner; Leigh Perreault; Rachel R Markwald; Mark R Smith; Andrew W McHill; Janine Higgins; Edward L Melanson; Kenneth P Wright Journal: Curr Biol Date: 2015-11-05 Impact factor: 10.834
Authors: C M Swanson; P J Blatchford; E S Orwoll; J A Cauley; E S LeBlanc; H A Fink; K P Wright; M E Wierman; W M Kohrt; K L Stone Journal: Osteoporos Int Date: 2019-05-28 Impact factor: 4.507